Image

ClassIntra® for Better Outcomes in Surgery - CIBOSurg

Recruiting
18 - 110 years of age
Both
Phase N/A

Powered by AI

Overview

Intra- and postoperative adverse events (iAEs/pAEs) occur in up to one third of all patients, may be devastating to patients and costly to health care systems. Up to 50% of these events are potentially preventable. As iAEs are highly associated with pAEs, systematic and routine recording of iAEs and discussing them during the sign-out of the WHO Surgical Safety checklist (WHO SSC) is a prerequisite for diminishing or avoiding pAEs. However, in contrary to the first two parts of the WHO SSC, adherence with the last part, the sign-out, is only about 50%. Hence, the aim of this project is to increase adherence and quality of the performance of the WHO SSC and to implement routine recording of iAEs during the sign-out to improve patient safety and quality of care and, ultimately, reduce healthcare costs. Implementation science principles will be applied with a hybrid implementation-effectiveness approach and a multifaceted, tailored implementation strategy, which will be co-developed involving all relevant stakeholders.

Eligibility

Inclusion Criteria:

  • All in-hospital patients (consecutive or random sample) undergoing surgery from general surgery, vascular, surgery, orthopaedics/traumatology and urology in the operating room with anaesthesia involvement

Exclusion Criteria:

  • Patients undergoing one-day-surgery (with or without anaesthesia-involvement)
  • Procedures without anaesthesia-involvement (in- or out-patient)
  • ASA risk classification (ASA) VI patients (brain-death, organ-donor)
  • Follow-up procedure of a patient already included in the study

Study details

Perioperative Patient Safety

NCT05818332

University Hospital, Basel, Switzerland

20 February 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.